Kenneth J Holroyd

Kenneth J Holroyd

UNVERIFIED PROFILE

Are you Kenneth J Holroyd?   Register this Author

Register author
Kenneth J Holroyd

Kenneth J Holroyd

Publications by authors named "Kenneth J Holroyd"

Are you Kenneth J Holroyd?   Register this Author

13Publications

350Reads

33Profile Views

Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use.

Drug Saf 2020 Jun;43(6):567-582

Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40264-020-00915-6DOI Listing
June 2020

Advocating for mutually beneficial access to shelved compounds.

Future Med Chem 2018 06 23;10(12):1395-1398. Epub 2018 May 23.

Vanderbilt Institute for Clinical & Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600, Nashville, TN 37203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc-2018-0090DOI Listing
June 2018

Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream.

Clin Infect Dis 2008 Dec;47(12):1537-45

Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98116-1597, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/593185DOI Listing
December 2008

Squalamine lactate reduces choroidal neovascularization in a laser-injury model in the rat.

Retina 2003 Dec;23(6):808-14

Retina Service Research Laboratories, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/retinajournal/2003/12000/Squala
Web Search
http://dx.doi.org/10.1097/00006982-200312000-00011DOI Listing
December 2003

A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

Clin Cancer Res 2003 Sep;9(11):4108-15

Department of Thoracic/Head and Neck Medical Oncology and Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
September 2003

A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor.

Clin Cancer Res 2003 Jul;9(7):2465-71

Institute for Drug Development, Cancer Therapy and Research Center and The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA.

View Article

Download full-text PDF

Source
July 2003

Effect of squalamine on iris neovascularization in monkeys.

Retina 2002 Dec;22(6):772-8

Department of Ophthalmology, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, LA 70112-2699, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00006982-200212000-00014DOI Listing
December 2002